echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92%

    Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92%

    • Last Update: 2021-07-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
















    Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92%




    Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92% Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92%

     

    (Fighting New Coronary Pneumonia) Cuba's first new coronavirus vaccine in Latin America has an effective rate of over 92%

    China News Service, Beijing, June 23.
    Havana News: On the 21st local time, the Cuban Biomedical Group announced that its self-developed new crown vaccine "Avdala" has an effective rate of 92.
    28%, making Cuba the first self-developed and manufactured company.
    Latin American countries for the new crown vaccine

    .

    According to Agence France-Presse, the Cuban Biomedical Group issued an announcement stating that the new crown vaccine "Avdara" developed by the Cuban Genetics and Bioengineering Center has an effective rate of 92.
    28% after three doses, making it the most effective in the world.
    One of the new crown vaccines

    .
    It is reported that "Avdala" has entered the final stage of clinical trials and will be officially authorized by relevant Cuban institutions at the end of June or early July

    .

    In addition, the Finlay Institute of Vaccines in Cuba announced on the 19th that its three-dose new crown vaccine "Sovereign 02" can reach an effective rate of 62% after two doses.
    This vaccine will also be approved in the near future

    .

    Cuban President Diaz-Canel praised on social media: “Even after the epidemic, the scientists at the Finlay Institute for Vaccine Research and the Center for Genetics and Bioengineering have overcome numerous obstacles and developed two exceptional models for us.
    Effective COVID-19 vaccine

    .
    "

    According to Turkey's Anadolu News Agency, Venezuela, Argentina, Mexico, Iran and other countries have expressed interest in purchasing Cuban self-developed vaccines
    .

    Since 2017, the U.
    S.
    government has implemented more than 240 measures to strengthen the blockade against Cuba, among which a number of new restrictions during the epidemic have severely hindered Cuba’s access to vaccine production materials

    .
    In May of this year, Cuba began mass vaccination in Havana, aimed at combating the "beta" mutant virus first discovered in South Africa

    .

    According to Cuban official statistics, nearly 1 million of the country's approximately 11.
    2 million people have completed the vaccination, and it is expected that approximately 1.
    7 million people will be vaccinated in the coming weeks

    .
    (Finish)

    Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.